Rab5a is overexpressed in oral cancer and promotes invasion through ERK/MMP signaling
- Authors:
- Published online on: August 10, 2017 https://doi.org/10.3892/mmr.2017.7214
- Pages: 4569-4576
-
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Abstract
Ras-related protein Rab-5A (Rab5a) has been identified to be overexpressed in several types of human cancer. However, its clinical significance and biological roles in oral cancer remain unclear. In the present study, the protein expression of Rab5a was examined in 79 cases of oral squamous cell carcinoma samples using immunohistochemistry. It was demonstrated that Rab5a protein was upregulated in 49.3% (39/79) of cancer samples. Small interfering RNA knockdown was performed on Detroit 562 cells with high endogenous expression. Rab5a transfection was performed in FaDu cells with low endogenous levels. Rab5a depletion was revealed to inhibit cell growth, invasion and colony formation while its overexpression facilitated cell growth, invasion, and colony formation. In addition, Rab5a facilitated cell cycle progression and cell migration. It was also demonstrated that Rab5a depletion downregulated and its overexpression upregulated the expression levels of various cell cycle‑associated proteins, and matrix metalloproteinase‑2 (MMP‑2). Furthermore, Rab5a positively regulated the extracellular signal‑regulated kinase (ERK) signaling pathway and promoted epithelial‑mesenchymal transition (EMT). ERK inhibitor PD98059 partially inhibited the role of Rab5a on MMP‑2, cyclin D1, cell proliferation and invasion. The results of the present study suggest that Rab5a is overexpressed in oral cancer tissue samples and promotes the malignant phenotype through EMT and the ERK/MMP‑2 signaling pathway.